Concepedia

Susan Colby

SC

Statistics

Publications

4

Citations

703

H-Index

4

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

Susan Colby is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacotherapy, and hyperpigmentation treatment.

Publications per year

2000–2015

4

Publications

4

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

Vladimir Coric, Christopher H. van Dyck, Stephen Salloway et al. · Archives of Neurology · 2012 · 369 citations

Medicine, Pharmacology, Pharmacotherapy +17

Targeting Prodromal Alzheimer Disease With Avagacestat

Vladimir Coric, Stephen Salloway, Christopher H. van Dyck et al. · JAMA Neurology · 2015 · 233 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies

E.H. Schwartzel, Susan Colby, David J. Altman · Journal of the American Academy of Dermatology · 2000 · 86 citations

Medicine, Dermatology, Ophthalmology +15

A promising new treatment for solar lentigines.

Susan Colby, E.H. Schwartzel, Ferdinand Huber et al. · PubMed · 2003 · 15 citations

Medicine, Dermatology, Pharmacotherapy +15

1–4 of 4